Harada Shinsuke, Tamura Fumihiko, Ota Shuhei
Department of Palliative Medicine, Kanagawa Cancer Center, Kanagawa, Japan
Department of Palliative Medicine, Kanagawa Cancer Center, Kanagawa, Japan.
Am J Hosp Palliat Care. 2016 Jul;33(6):594-8. doi: 10.1177/1049909115577353. Epub 2015 Mar 20.
The primary aim of this study was to determine the prevalence of neuropathic pain (NP) in patients with cancer receiving palliative care.
In this prospective observational study, terminally ill patients with cancer having NP were identified by a pain management clinician using the diagnostic algorithm of NP from the International Association for the Study of Pain on the day of admission.
A total of 220 patients who were hospitalized in the palliative care unit were enrolled in this study. The median survival times were 21.5 days (range, 0-173 days), and 57.7% of patients were male. Among the 220 patients, 41 (18.6%; 95% confidence interval, 13.5%-23.8%) developed NP.
The prevalence of NP in terminally ill patients with cancer in Japanese palliative care units was 18.6%.
本研究的主要目的是确定接受姑息治疗的癌症患者中神经性疼痛(NP)的患病率。
在这项前瞻性观察研究中,疼痛管理临床医生在入院当天使用国际疼痛研究协会的NP诊断算法识别患有NP的晚期癌症患者。
共有220名入住姑息治疗病房的患者纳入本研究。中位生存时间为21.5天(范围0 - 173天),57.7%的患者为男性。在这220名患者中,41名(18.6%;95%置信区间,13.5% - 23.8%)发生了NP。
日本姑息治疗病房中晚期癌症患者的NP患病率为18.6%。